ROCKVILLE, MD -- (MARKET WIRE) -- 06/22/09 -- MarketResearch.com has announced the addition of Kalorama Information's new report "Rx to OTC Switches 2009," to their collection of Healthcare market reports. For more information, visit http://www.marketresearch.com/redirect.asp?progid=67618&productid=2196300

While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over the counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of this decade there was a delcine in Rx to switches, since 2006 there has been a number of uses of this tactic to extend revenue of pharmaceutical products. In Kalorama Information's Rx to OTC Switches 2009, we take a look at recent swtiches, products that may switch in the future, and categories that can benefit most from an OTC product.

The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.

All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.

As part of its coverage, this report includes

--  Current Market for Rx to OTC across major categories
--  Past Results of OTC Switches
--  Products Most Likely to Switch to OTC
--  Assessment of the Economic Downturn's Impact
    

The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available:

Please enable Javascript

--  Allergy, Cough, Cold, and Sinus Products
--  Analgesics, NSAIDs, and Pain Treatments
--  Anti-Infectives
--  Gastrointestinal Drugs
--  Hair Loss Products
--  Hormones
--  Oral Care
--  Rectal Ointments
--  Sleep-aids
--  Smoking Cessation
--  Weight Loss
    

In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future, including: Cholesterol-reducing Drugs, Osteoporosis Treatments, Overactive Bladder and Sexual Dysfunction. The report covers OTC drugs that were once only available by prescription due to either the active ingredient or dosage of the drug.

Current and historical revenues for product segments include both the switched brands and OTC drugs containing switched ingredients. Forecasted data includes current products and forecasted switches which are outlined in the report.

The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future, including:

--  Regulatory Actions
--  A Third Class of Drug
--  Insurance Issues and Reimbursement for OTC Drugs
--  Health Insurance Trends in the United States
--  Healthcare Flexible Spending Accounts and OTC Medicines: Impact on the
    Consumer
--  Online Resources for Health Information
--  OTC Availability
--  Health Expenditures
--  Pharmacists Role
--  Impact on the Prescription Drug Manufacturer
--  Strategies for Continued Product Growth
--  Dual Status Switching
--  Generic Competition
--  Direct-to-Consumer Advertising
--  Patent Expiration
--  Labeling Changes
--  International Trends in Rx-to-OTC Switches
--  Prescription vs Over-the-Counter Industry
--  Declining Growth of the World Population
    

Topics covered in the report include...
Chapter One: Executive Summary
   Scope and Methodology
   Size and Growth of the Market
   Issues and Trends Affecting the Rx-to-OTC Switches Market
   Leading Competitors
Chapter Two
Introduction
   Overview of the Over-the-Counter Market
   Development of the Rx-to-OTC Drug Market
   Rx-to-OTC Industry Structure
   Economic Indicators
   The FDA and Rx-to-OTC Switches

Chapter Three
Allergy, Cough, Cold, and Sinus Products
   Overview
   Antihistamines
   Decongestants
   Cough Preparations
   Mast Cell Stabilizers
   Ophthalmic Preparations
   Description of Conditions
   Allergic Rhinitis
   Common Cold
   Sinusitis
   Hives
   Ocular Allergies
   Prevalence and Incidence
   Product Analysis
   Current OTC Switched Products
   Antihistamines
   Decongestants
   Cough Preparations
   Mast Cell Stabilizers
   Ophthalmic Preparations
   Prescription Products with Anticipated OTC Approvals
   Allegra
   Clarinex
   Flonase
   Nasacort AQ
   Nasonex
   Market Analysis
   Market Size and Forecast
   Competitive Analysis

Chapter Four
Analgesics and Other Pain Relievers
   Overview
   Analgesics
   Nonsteroidal Anti-inflammatory Drugs
   Topical Pain Relievers and Other Similar Products
   Description of Conditions
   Pain
   Inflammation
   Prevalence and Incidence
   Product Analysis
   Current OTC Switched Products
   Antipruritic
   Internal analgesic/antipyretic
   Oral anesthetic
   Prescription Products with Anticipated OTC Approvals
   Nonsteroidal anti-inflammatory drugs
   Migraine treatments
   Market Analysis
   Market Size and Forecast
   Competitive Analysis

Chapter Five
Anti-infectives
   Overview
   Antibiotics
   Antifungals
   Antivirals
   Antiparasitics
   Description of Conditions
   Vaginal Infections
   Athlete's Foot
   Jock Itch
   Ringworm
   Dandruff
   Scabies and Pediculosis
   Pinworm
   Fungal Nail Infections
   Prevalence and Incidence
   Product Analysis
   Current OTC Switched Products
   Prescription Products with Anticipated OTC Approvals
   Antivirals
   Antibiotics
   Antifungals
   Market Analysis
   Market Size and Forecast
   Competitive Analysis

Chapter Six
Gastrointestinal Drugs
   Overview
   Description of Conditions
   Nausea
   Diarrhea
   Constipation
   Heartburn
   Acid reflux
   Prevalence and Incidence
   Product Analysis
   Current OTC Switched Products
   Histamine H2 Inhibitors
   Proton Pump Inhibitors
   Antidiarrheals
   Laxatives
   Antiemetics
   Prescription Products with Anticipated OTC Approvals
   Proton Pump Inhibitors
   Mucosal Protectants
   Antiemetics
   Market and Competitive Analysis
   Market Size and Forecast
   Competitive Analysis

Chapter Seven
Smoking Cessation
   Overview
   Description of Conditions
   Prevalence and Incidence
   Lung Cancer and Tobacco Use
   Product Analysis
   Current OTC Switched Products
   Prescription Products with Anticipated OTC Approvals
   Market Analysis
   Market Size and Forecast
   Competitive Analysis

Chapter Eight
Other Drug Classifications
   Overview
   Contraceptives
   Dental Rinses and Fluorides
   Hair Growth Products
   Rectal Ointments
   Sleep Aids
   Weight Management
   Description of Conditions
   Pregnancy
   Dental carries
   Hereditary Hair Loss
   Hemorrhoids
   Sleeplessness
   Obesity
   Conditions with Possible Future OTC Treatments
   Elevated Cholesterol
   Osteoporosis
   Acne Vulgaris
   Menopause and Hormone Replacement
   Prevalence and Incidence
   Product Analysis
   Current OTC Switched Products
   Contraceptives
   Dental rinses and fluoride
   Hair growth
   Rectal ointments
   Sleep aids
   Weight Management
   Prescription Products with Anticipated OTC Approvals
   Antilipidemics/ Osteoporosis/ Hormone Replacement
   Hair Loss Treatment
   Acne Treatments
   Overactive Bladder
   Sexual Dysfunction
   Market Analysis
   Market Size and Forecast
   New Product Segments; Post 2013
   Osteoporosis and Hormone Replacement
   Overactive Bladder
   Sexual Dysfunction
   Competitive Analysis

Chapter Nine
Total Market Summary
   Overview
   Total market Size and Forecast
   Competitive Analysis
   Market Analysis

Chapter Ten: Issues and Trends Affecting the Rx-to-OTC Market
Introduction
   Regulatory Authorities
   A Third Class of Drug
   Insurance Issues and Reimbursement for OTC Drugs
   Health Insurance Trends in the United States
   Healthcare Flexible Spending Accounts and OTC Medicines
   Impact on the Consumer
   Online Resources for Health Information
   OTC Availability
   Health Expenditures
   Pharmacists Role
   Impact on the Prescription Drug Manufacturer
   Strategies for Continued Product Growth
   Dual Status Switching
   Generic Competition
   Direct-to-Consumer Advertising
   Patent Expiration
   Labeling Changes
   International Trends in Rx-to-OTC Switches
   Prescription vs Over-the-Counter Industry
   World Health, Demographics and Life Expectancy
   Life Expectancy
   Declining Growth of the World Population
   Birth Rates

Chapter Eleven: Company Profiles
   Introduction
   GlaxoSmithKline
   Johnson & Johnson
   Novartis
   Procter & Gamble
   Schering-Plough
   Wyeth


APPENDIX: Company Directory

Table of Contents

List of Exhibits

Chapter One

Executive Summary

   Table 1-1 - The U.S. Market for Rx-to-OTC Switches 2004-2013 Compound
   Annual Growth Rate

   Figure 1-1 - The U.S. Market for Rx-to-OTC Switches, 2004-2013

Chapter Two
Introduction

   Table 2-1 - OTC Retail Sales, 1976-2007

   Table 2-2 - Rx-to-OTC Switches Approved by the FDA 1976-2007

   Figure 2-1 - Number of New Rx-to-OTC Switches per Year 1976-2007

   Table 2-3 - Statistics for Selected Rx-to-OTC Switches (United States)

   Table 2-4 - Estimated OTC Sales by Product Type and Percent of Sales
   Attributed to Rx-to-OTC Switched Ingredients

   Table 2-5 - U.S. Population by Sex and Selected Age Group, 1997-2017

   Figure 2-2 - U.S. Population by Sex, 1997-2017

   Figure 2-3 - U.S. Population by Selected Age Group, 1997-2017

   Table 2-6 - Healthcare Industry Inflation Rates Healthcare Industry
   Consumer Price Index Comparisons Based on 2008 Data

   Figure 2-4 - Healthcare Industry Inflation Rates Healthcare Industry
   Consumer Price Index Comparisons Based on 2008 Data

Chapter Three
Allergy, Cough, Cold, and Sinus Products

   Table 3-1 - United States Incidence of Allergy, Cough, Cold, Sinus
   Conditions 2008

   Figure 3-1 - United States Incidence of Allergy, Cough, Cold, Sinus
   Conditions, Superimposed on Total Population, 2008

   Table 3-2 - Allergy, Cough, Cold, Sinus Product Ingredients
   Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date
   of OTC Approval

   Table 3-3 - Prescription Drugs with Anticipated OTC Approval by
   Ingredient, Trade Name, Distributor and Current Activity

   Table 3-4 - The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold,
   and Sinus Product Revenues 2004-2008
   Compound Annual Growth Rate

   Table 3-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Allergy,
   Cough, Cold, and Sinus Product Revenues 2009-2013
   Compound Annual Growth Rate

   Figure 3-2 - The U.S. Market for Rx-to-OTC Switches Allergy, Cough,
   Cold, and Sinus Product Revenues 2004-2013

   Figure 3-3 - The U.S. Market for Rx-to-OTC Switches: Allergy, Cough,
   Cold, and Sinus Products, by Percent and Product Type, 2008

   Table 3-6 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches: Allergy, Cough, Cold, and Sinus Products, 2008

   Figure 3-4 - Leading Suppliers' Shares of the U.S. Market for
   Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, 2008

Chapter Four
Analgesics and Other Pain Relievers

   Table 4-1 - United States Incidence of Conditions with Pain and
   Inflammatory Symptoms 2008

   Figure 4-1 - United States Incidence of Conditions with Pain and
   Inflammatory Symptoms Superimposed on Total Population, 2008

   Table 4-2 - Analgesics, NSAIDs and Other Ingredients Transferred from
   Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval

   Table 4-3 - Prescription Drugs with Anticipated OTC Approval by
   Ingredient, Trade Name, Distributor and Current Activity

   Table 4-4 - The U.S. Market for Rx-to-OTC Switches Analgesic Product
   Revenues 2004-2008
   Compound Annual Growth Rate

   Table 4-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Analgesic
   Product Revenues 2009-2013
   Compound Annual Growth Rate

   Figure 4-2 - The U.S. Market for Rx-to-OTC Switches Analgesic Product
   Revenues 2004-2013

   Figure 4-3 - The U.S. Market for Rx-to-OTC Switches: Analgesic Product
   Type, 2008

   Table 4-6 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches Analgesics 2008

   Figure 4-4 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches Analgesics 2008

Chapter Five
Anti-infectives

   Table 5-1 - United States Yearly Incidence of Infections, 2008

   Figure 5-1 - United States Yearly Incidence of Infections Superimposed
   on Total Population, 2008

   Table 5-2 - Anti-infectives Ingredients Transferred from Rx-to-OTC
   Status by Trade Name, Distributor, and Date of OTC Approval

   Table 5-3 - Prescription Drugs with Anticipated OTC Approval by
   Ingredient, Trade Name, Distributor and Current Activity

   Table 5-4 - The U.S. Market for Rx-to-OTC Switches Anti-infective
   Product Revenues 2004-2008
   Compound Annual Growth Rate

   Table 5-5 - The Forecasted U.S. Market for Rx-to-OTC Switches
   Anti-infective Product Revenues 2009-2013
   Compound Annual Growth Rate

   Figure 5-2 - The U.S. Market for Rx-to-OTC Switches Anti-infective
   Product Revenues 2004-2013

   Figure 5-3 - The U.S. Market for Rx-to-OTC Switches: Anti-infective
   Product Type, 2008

   Table 5-6 - Leading Suppliers' Shares of The U.S. Market for Rx-to-OTC
   Switched Anti-infectives 2008

   Figure 5-4 - Leading Suppliers' Shares of The U.S. Market for Rx-to-OTC
   Switched Anti-infectives 2008

Chapter Six
Gastrointestinal Drugs

   Table 6-1 - United States Incidence of Gastrointestinal Conditions 2008

   Table 6-2 - Gastrointestinal Drug Ingredients Transferred from Rx-to-OTC
   Status by Trade Name, Distributor, and Date of OTC Approval

   Table 6-3 - Prescription Drugs with Anticipated OTC Approval by
   Ingredient, Trade Name, Distributor and Current Activity

   Table 6-4 - The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drug
   Revenues 2004-2008
   Compound Annual Growth Rate

   Table 6-5 - The Forecasted U.S. Market for Rx-to-OTC Switches
   Gastrointestinal Drug Revenues 2009-2013
   Compound Annual Growth Rate

   Figure 6-2 - The U.S. Market for Rx-to-OTC Switches Gastrointestinal
   Drug Revenues 2004-2013

   Figure 6-3 - The U.S. Market for Rx-to-OTC Switches: Gastrointestinal
   Drug by Product Type, 2008

   Table 6-6 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches Gastrointestinal Drugs 2008

   Figure 6-4 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches Gastrointestinal Drugs 2008

Chapter Seven
Smoking Cessation

   Table 7-1 - United States Cigarette Usage in Percent by Age Group, 2006

   Figure 7-1 - New Lung Cancer Cases and Deaths for 2008 by Gender,
   United States

   Table 7-2 - New Cases of Lung and Bronchus Cancer by State; Deaths from
   Lung and Bronchus Cancer by State, 2008 Estimates

   Table 7-3 - Smoking Cessation Product Ingredients Transferred from
   Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval

   Table 7-4 - Prescription Drugs with Anticipated OTC Approval by
   Ingredient, Trade Name, Distributor and Current Activity

   Table 7-5 - The U.S. Market for Rx-to-OTC Switches Smoking Cessation
   Product Revenues 2004-2008
   Compound Annual Growth Rate

   Table 7-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Smoking
   Cessation Product Revenues 2009-2013
   Compound Annual Growth Rate

   Figure 7-2 - The U.S. Market for Rx-to-OTC Switches Smoking Cessation
   Product Revenues 2004-2013

   Figure 7-3 - The U.S. Market for Rx-to-OTC Switches: Smoking Cessation
   Product Type, 2008

   Table 7-8 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches Smoking Cessation Drugs 2008

   Figure 7-5 - Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC
   Switches Smoking Cessation Drugs 2008

Chapter Eight
Other Drug Classifications

   Table 8-1 - United States Incidence of Miscellaneous Conditions for
   Which There Are Potential Rx-to-OTC Switches 2008

   Table 8-2 - Estimated U.S. Contraceptive Use by Method, Five Year
   Average 2007/2008

   Table 8-3 - Miscellaneous Drug Ingredients Transferred from Rx-to-OTC
   Status by Trade Name, Distributor, and Date of OTC Approval

   Table 8-3 - Prescription Drugs with Anticipated OTC Approval by
   Ingredient, Trade Name, Distributor and Current Activity

   Table 8-4 - The U.S. Market for Rx-to-OTC Switches Other Drug
   Classification Product Revenues 2004-2008
   Compound Annual Growth Rate

   Table 8-5 - The Forecasted U.S. Market for Rx-to-OTC Switches Other Drug
   Classification Product Revenues 2009-2013
   Compound Annual Growth Rate

   Figure 8-2 - The U.S. Market for Rx-to-OTC Switches Other Drug
   Classification Product Revenues 2004-2013

   Table 8-6 - The U.S. Market for Rx-to-OTC Switches Other Drug
   Classifications Revenues by Product Type 2004-2013
   Compound Annual Growth Rate

   Figure 8-3 - The U.S. Market for Rx-to-OTC Switches Other Drug
   Classifications Revenues by Product Type 2004-2013

   Figure 8-4 - The U.S. Market for Rx-to-OTC Switches Other Drug
   Classifications Distribution of Revenues by Product Type 2008

   Table 8-7 - Leading Suppliers' Shares of the U.S. Market for
   Rx-to-OTC Switches Other Drug Classifications 2008

   Figure 8-5 - Leading Suppliers' Shares of the U.S. Market for
   Rx-o-OTC Switches Other Drug Classifications 2008

Chapter Nine
Total Market Summary

   Table 9-1 - The U.S. Market for Rx-to-OTC Switches 2004-2013
   Compound Annual Growth Rate

   Figure 9-1 - The U.S. Market for Rx-to-OTC Switches, 2004-2013
   Markets by Segments

   Figure 9-2 - The U.S. Market for Rx-to-OTC Switches by Product Category,
   2004-2013

   Figure 9-3 - The U.S. Market for Rx-to-OTC Switches, Distribution of
   Revenues by Product Category 2008

   Table 9-4 - Leading Suppliers Significant Segments of Participation
   within the U.S. Market for Rx-to-OTC Switches, 2008

   Figure 9-4 - Leading Suppliers Market Share in the U.S. Market for
   Rx-to-OTC Switches, 2008

Chapter Ten : Issues and Trends Affecting the Rx-to-OTC Market

   Table 10-1: Health Insurance Trends in the United States 2003-2006

   Table 10-2: National Healthcare Expenditures in the United States
   1960-2010

   Figure 10-1: Healthcare Spending as a Percent of GDP in the
   United States

   Figure 10-2: Internet Users per 100 Inhabitants, 1994-2006

   Table 10-3:Total Healthcare Expenditures as a Percent of GDP by Country
   2004 and 2006

   Figure 10-3: Total Healthcare Expenditures as a Percent of GDP by
   Country 2004 and 2006

   Table 10-4: Average Annual Expenditures per Consumer Unit for
   Healthcare 2004-2006

   Figure 10-4: Typical Pharmacist-Consumer OTC Drug Counseling Session

   Table 10-5: U.S. Patent Expirations for Select Prescription
   Pharmaceuticals

   Table 10-6: Legal Classification Status of Selected Ingredients
   Worldwide

   Table 10-7: Total Pharmaceutical Markets, Prescription vs.
   Non-Prescription by Region, 2007

   Figure 10-5: Total Pharmaceutical Markets, Prescription vs.
   Non-Prescription by Region, 2007

   Table 10-8: Average Life Expectancy in Years by Country 1980 and 2008

   Figure 10-6: Average Life Expectancy in Years by Country 1980 and 2008

   Table 10-9: World Population 1980 to 2050

   Figure 10-7: World Population 1980 to 2050

   Table 10-10: Crude Birth Rate per 1,000 Persons 2000, 2005 and
   Projected 2010

   Figure 10-8: Crude Birth Rate per 1,000 Persons 2000, 2005 and
   Projected 2010

Please enable Javascript

For more information visit http://www.marketresearch.com/redirect.asp?progid=67618&productid=2196300

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Gregg Kellett
MarketResearch.com
gkellett@marketresearch.com
240.747.3008